MRSN MRSN

Mersana Therapeutics Stock Price

7.63
0.18 (2.42%)
Upgrade to Real-Time
Afterhours (Closed)
7.63
Volume 1,148,474
Bid Price 7.15
Ask Price 8.59
News -
Day High 7.9261

Low
2.68

52 Week Range

High
14.80

Day Low 7.50
Company Name Stock Ticker Symbol Market Type
Mersana Therapeutics Inc MRSN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.18 2.42% 7.63 00:00:05
Open Price Low Price High Price Close Price Prev Close
7.50 7.50 7.9261 7.57 7.45
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
11,745 1,148,474 $ 7.69 $ 8,828,197 - 2.68 - 14.80
Last Trade Time Type Quantity Stock Price Currency
19:58:24 66 $ 7.50 USD

Period:

Draw Mode:

Mersana Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 741.40M 97.17M 96.39M $ 44.00k $ - -2.40 -3.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 1.24M 1.20%

more financials information »

Mersana Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MRSN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.928.024.856.885,035,0152.7155.08%
1 Month5.748.024.836.301,943,2141.8932.93%
3 Months3.518.022.9155.131,538,7314.12117.38%
6 Months4.338.022.684.511,584,6173.3076.21%
1 Year11.8714.802.685.621,341,740-4.24-35.72%
3 Years3.0729.091.3211.611,013,5164.56148.53%
5 Years15.5029.091.3211.47670,105-7.87-50.77%

Mersana Therapeutics Description

Mersana Therapeutics Inc is a clinical stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefit to patients. Mersana's product candidate, XMT-1536, is in a Phase 1 clinical trial in patients with tumors expressing NaPi2b, including ovarian cancer, NSCLC, and other cancers. In addition, multiple partners are using Mersana's platform to advance their ADC pipelines.


Your Recent History
NASDAQ
MRSN
Mersana Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now